Antipsychotic medicines in Australian community practice: Effectiveness, adverse effects and quality of life for people with schizophrenia

Grants

Funding Acknowledgements

This study was directly funded by the National Institute of Clinical Studies (NICS), Australia's national agency for improving healthcare by helping close important gaps between best available evidence and current clinical practice. NICS is funded by the Australian Government. The authors have no other relevant financial interests to declare.